发明名称 |
Pharmaceutical coposition |
摘要 |
<p>A composition comprising a compound of formula (I)
wherein
R represents a halogen atom or a C 1-4 alkyl group;
R 1 represents a C 1-4 alkyl group;
R 2 represents hydrogen or a C 1-4 alkyl group;
R 3 represents hydrogen, or a C 1-4 alkyl group;
R 4 represents a trifluoromethyl group;
R 5 represents hydrogen, a C 1-4 alkyl group or C(O)R 6 ;
R 6 represents C 1-4 alkyl, C 3-7 cycloalkyl, NH(C 1-4 alkyl) or N(C1-4alkyl) 2 ;
m is zero or an integer from 1 to 3;
n is an integer from 1 to 3 or pharmaceutically acceptable salts or solvates thereof and a selective serotonin reuptake inhibitor.</p> |
申请公布号 |
EP1752449(A1) |
申请公布日期 |
2007.02.14 |
申请号 |
EP20060122021 |
申请日期 |
2001.10.12 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
ALVARO, GIUSEPPE;DI FABIO, ROMANO;MARAGNI, PAOLO;TAMPIERI, MARISA;TRANQUILLINI, MARIA ELVIRA |
分类号 |
C07D211/58;A61K31/445;A61K31/496;A61P25/00;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P25/36 |
主分类号 |
C07D211/58 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|